Conference
UNDERSTANDING AND TARGETING RESISTANCE IN GLIOBLASTOMA (UNITE GLIOBLASTOMA)
We are pleased to announce the UNITE Glioblastoma Conference, focused on “Understanding and Targeting Resistance in Glioblastoma,” to be held at the DKFZ Communication Center in Heidelberg, Germany, on May 14th and 15th, 2025.
This conference aims to bring together leading experts from around the world to discuss the latest research and developments in glioblastoma resistance.
Glioblastoma remains one of the most challenging and aggressive forms of cancer, with resistance to current therapies posing a major hurdle in improving patient outcomes. Recent studies have provided new insights into the mechanisms of resistance and potential strategies to overcome them, paving the way for innovative approaches in treatment.
The conference will feature keynote presentations by internationally recognized experts, as well as oral and poster presentations by researchers at the forefront of glioblastoma research. In addition to the scientific sessions, there will be ample opportunities for networking and informal discussions with colleagues, fostering collaboration and the exchange of ideas.
Join us for an in-person conference, where the latest findings in glioblastoma resistance will be explored in depth.
With best regards,
UNITE Glioblastoma Conference Organizing Committee
REGISTRATION
Registration is open! Please follow the link.
ABSTRACT SUBMISSION
Abstract submission is open! Please upload you abstract by using this link
Submission deadline: February 23rd 2025, deadline extended to March 23rd!
Abstract guidelines
Submission categories:
- Metabolic Crosstalk
- Tumor Microenvironment
- Clinical Trials
- Gliomagenesis & Neurodevelopment
- Immunotherapy
- Liquid Biopsies
- Neuropathology/Classification
- Tumor Heterogeneity
- Tools and techniques shaping the future of brain tumor research
Title:
- Capital letters only where necessary
- No line breaks in the title
- Use italics only where required by nomenclature
- Maximum of 25 words
Authors:
- Format: First name and family name, e.g. Max Mustermann, Heidelberg University Hospital (UKHD), Heidelberg, Germany
- No more than 35 authors
- Maximum of 2 affiliations per author
Abstract text:
- 250-400 words
- Must be written in good English
- No tables, graphics, or illustrations
- No citation of literature